Mesothelioma Cancer Resources Blog

Source: Yahoo News Dutch researchers have completed the first study looking at the emergence of post-traumatic stress disorder (PTSD) symptoms in children with a parent who has been diagnosed with a form of cancer. The study enrolled children between the ages of 11 and 18 and tracked them throughout the course of their parent’s illness. …

Source: DocGuide.com A study presented at the 14th European Cancer Conference found that pemetrexed, marketed by Eli Lilly & Company as Alimta®, used alone or with a platinum agent, shows good response rates and disease control rates in patients with peritoneal mesothelioma, the second-most common variant of mesothelioma. The study is one of the first …

Source: Avemar Research The proper identification of the histologic subtype of malignant pleural mesothelioma is an important element both in the diagnosis of the disease and the treatment regimen that a patient is given. There are three histological subtypes of the disease, each with a different average prognosis. The most common subtype is epithelial mesothelioma; …

Source: CNN.com The CNN.com Health section details a listing of healthy food types that should be an important part of everyone’s diet. Eating well is an essential element of a healthy lifestyle and the foods listed are excellent sources of general nutrition. Calcium. Calcium is a key element for healthy bones and many other body functions. …

Source: Eli Lilly Eli Lilly has submitted an application with the European Medicines Agency (EMEA) for the approval of Alimta®, in combination with cisplatin, as a first-line treatment for advanced non-small cell lung cancer (NSCLC). The EMEA has previously approved Alimta as a single agent, second-line therapy for advanced NSCLC. The submission is based on …

Source: ScienceDaily.Com Researchers from the Georgia Institute of Technology have developed a sensor that can quickly and accurately detect the presence of mesothelin, a protein whose expression is strongly linked to a number of cancers—including mesothelioma, ovarian cancer and pancreatic cancer—in a simple blood sample taken in a doctor’s office. The sensor, known as the …

Source: Alfacell Press Release Alfacell Corporation is currently conducting a Phase III-b clinical trial of Onconase® in patients with unresectable malignant mesothelioma. Alfacell has developed Onconase® using its proprietary ribonuclease (RNase) technology. The treatment compound is a protein derived from the leopard frog and has been shown in laboratory and clinical trials to attack cancer …

Source: Wall Street Journal In a supplement published in the medical journal Chest, the American College of Chest Physicians offered the first comprehensive analysis on the use of alternative and complementary medicine in the treatment of lung cancer. The researchers examined over 100 published studies regarding alternative or complementary medicine in an attempt to quantify …

Source: CNNMoney.Com Results from recent studies confirm that Alimta®, Eli Lilly’s FDA-approved drug for mesothelioma, does have clinical efficacy for the treatment of malignant pleural mesothelioma. The studies looked at Alimta given as a single agent and in combination with a platinum agent, such as cisplatin or carboplatin—which is the standard chemotherapy treatment for mesothelioma. …

Source: MedPage Today At a recent International Association for the Study of Lung Cancer meeting, a group of Nordic researchers released the surprising results of a study that showed certain mesothelioma patients can have a much longer life expectancy than is normally assumed. In the Nordic study, patients with the epithelial subtype of mesothelioma were …